Fiduciary Family Office LLC Takes $714,000 Position in The Clorox Company (NYSE:CLX)

Key Points

• Fiduciary Family Office LLC acquired 4,852 shares of The Clorox Company (NYSE:CLX), valued at approximately $714,000, marking a new position in the company's stock.
• Several institutional investors have increased their stakes in Clorox, with institutional ownership now at 78.53% of the company's stock.
• Clorox recently announced a quarterly dividend of $1.24 per share, which represents a 4.0% annual yield and an increase from its previous dividend of $1.22.

Fiduciary Family Office LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 4,852 shares of the company's stock, valued at approximately $714,000.

Other institutional investors have also recently made changes to their positions in the company. Redwood Park Advisors LLC bought a new stake in shares of Clorox in the fourth quarter worth about $26,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Clorox during the 4th quarter valued at about $31,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Clorox during the 4th quarter valued at about $32,000. GW&K Investment Management LLC raised its position in shares of Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after buying an additional 208 shares in the last quarter. Finally, Roble Belko & Company Inc raised its position in shares of Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after buying an additional 211 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Down 0.9%

Shares of CLX traded down $1.19 during trading hours on Friday, reaching $124.89. 1,299,586 shares of the company traded hands, compared to its average volume of 1,869,570. The firm has a market cap of $15.39 billion, a price-to-earnings ratio of 19.16, a PEG ratio of 1.00 and a beta of 0.49. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock's fifty day moving average price is $125.51 and its 200 day moving average price is $137.64.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business's revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.82 earnings per share. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is currently 74.85%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Jefferies Financial Group decreased their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Morgan Stanley decreased their target price on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Finally, UBS Group decreased their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $143.36.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.